JP2015517482A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015517482A5 JP2015517482A5 JP2015510838A JP2015510838A JP2015517482A5 JP 2015517482 A5 JP2015517482 A5 JP 2015517482A5 JP 2015510838 A JP2015510838 A JP 2015510838A JP 2015510838 A JP2015510838 A JP 2015510838A JP 2015517482 A5 JP2015517482 A5 JP 2015517482A5
- Authority
- JP
- Japan
- Prior art keywords
- tissue targeting
- complex
- targeting moiety
- moiety
- hopo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1208309.3 | 2012-05-11 | ||
| GB201208309A GB201208309D0 (en) | 2012-05-11 | 2012-05-11 | Complexes |
| PCT/EP2013/059839 WO2013167754A1 (en) | 2012-05-11 | 2013-05-13 | Radio-pharmaceutical complexes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015517482A JP2015517482A (ja) | 2015-06-22 |
| JP2015517482A5 true JP2015517482A5 (https=) | 2017-08-17 |
| JP6211066B2 JP6211066B2 (ja) | 2017-10-11 |
Family
ID=46458687
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015510838A Expired - Fee Related JP6211066B2 (ja) | 2012-05-11 | 2013-05-13 | 放射性医薬錯体 |
| JP2015510839A Pending JP2015523326A (ja) | 2012-05-11 | 2013-05-13 | 放射性医薬錯体 |
| JP2015510840A Expired - Fee Related JP6219372B2 (ja) | 2012-05-11 | 2013-05-13 | 放射性医薬錯体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015510839A Pending JP2015523326A (ja) | 2012-05-11 | 2013-05-13 | 放射性医薬錯体 |
| JP2015510840A Expired - Fee Related JP6219372B2 (ja) | 2012-05-11 | 2013-05-13 | 放射性医薬錯体 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20150147272A1 (https=) |
| EP (3) | EP2846843A1 (https=) |
| JP (3) | JP6211066B2 (https=) |
| KR (3) | KR20150092701A (https=) |
| CN (3) | CN104619355A (https=) |
| CA (3) | CA2873142A1 (https=) |
| GB (1) | GB201208309D0 (https=) |
| HK (3) | HK1206981A1 (https=) |
| WO (3) | WO2013167756A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8557601B2 (en) | 2006-07-10 | 2013-10-15 | The Regents Of The University Of California | Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides |
| WO2011025790A1 (en) | 2009-08-24 | 2011-03-03 | Lumiphore, Inc. | Macrocyclic hopo chelators |
| GB201002508D0 (en) | 2010-02-12 | 2010-03-31 | Algeta As | Product |
| GB201208309D0 (en) | 2012-05-11 | 2012-06-27 | Algeta As | Complexes |
| US11453652B2 (en) | 2013-03-15 | 2022-09-27 | Lumiphore, Inc. | Di-macrocycles |
| MA41176A (fr) * | 2014-12-17 | 2017-10-24 | Bayer As | Complexes radio-pharmaceutiques |
| US10821195B2 (en) * | 2015-09-10 | 2020-11-03 | Memorial Sloan Kettering Cancer Center | Compositions for therapeutics, targeted PET imaging and methods of their use |
| GB201600158D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Purification method |
| GB201600154D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Isotope preparation method |
| SG10202009424TA (en) | 2016-03-24 | 2020-11-27 | Bayer Pharma AG | Radio-pharmaceutical complexes |
| CN109689115A (zh) | 2016-06-10 | 2019-04-26 | 拜耳制药股份公司 | 放射性药物配合物 |
| WO2018153975A1 (en) * | 2017-02-24 | 2018-08-30 | Bayer As | Combination therapy comprising a radiopharmaceutical and a dna-repair inhibitor |
| EA202092044A1 (ru) * | 2018-03-14 | 2021-03-03 | Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез | Химерные рецепторы антигена против cd33 и их применения |
| US20210187134A1 (en) | 2018-08-28 | 2021-06-24 | Bayer As | Combination of pi3k-inhibitors and targeted thorium conjugates |
| JP7699542B2 (ja) * | 2018-11-20 | 2025-06-27 | コーネル ユニバーシティー | 放射線核種の大環状錯体およびがんの放射線療法におけるそれらの使用 |
| USD885822S1 (en) | 2018-12-14 | 2020-06-02 | Whirlpool Corporation | Food grinder |
| US20220125960A1 (en) | 2019-02-21 | 2022-04-28 | Bayer Aktiengesellschaft | Combination of pd-1/pd-l1 inhibitors and targeted thorium conjugates |
| WO2020169538A1 (en) | 2019-02-22 | 2020-08-27 | Bayer Aktiengesellschaft | Combination of ar antagonists and targeted thorium conjugates |
| WO2021013978A1 (en) | 2019-07-25 | 2021-01-28 | Bayer As | Targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancer |
| BR112022013678A2 (pt) * | 2020-01-10 | 2022-11-16 | Fusion Pharmaceuticals Inc | Quelatos macrocíclicos e seus usos |
| CN115916731A (zh) * | 2020-01-23 | 2023-04-04 | 瑞德兰有限责任公司 | 用于制备定制的放射性同位素溶液的系统和方法 |
| CN116685602A (zh) * | 2020-11-30 | 2023-09-01 | 先声创新公司 | 用于同种异体细胞治疗的通用嵌合抗原受体表达免疫细胞 |
| CN116745323A (zh) | 2021-01-22 | 2023-09-12 | 拜耳股份有限公司 | Lrrc15抗体及其缀合物 |
| CN121793988A (zh) | 2023-09-13 | 2026-04-03 | 东丽株式会社 | 癌的治疗、预防和/或诊断用药物组合物 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4698431A (en) * | 1985-11-12 | 1987-10-06 | The United States Of America As Represented By The United States Department Of Energy | Hydroxypyridonate chelating agents |
| US5624901A (en) * | 1994-04-15 | 1997-04-29 | The Regents Of The University Of California | 3-hydroxy-2(1H)-pyridinone chelating agents |
| US8383081B2 (en) * | 1999-05-10 | 2013-02-26 | Immunomedics, Inc. | Anti-CD74 immunoconjugates and methods of use |
| NO312708B1 (no) | 2000-02-21 | 2002-06-24 | Anticancer Therapeutic Inv Sa | Radioaktive liposomer til terapi |
| NO313180B1 (no) | 2000-07-04 | 2002-08-26 | Anticancer Therapeutic Inv Sa | Bensökende alfapartikkel emitterende radiofarmasöytika |
| GB0308731D0 (en) | 2003-04-15 | 2003-05-21 | Anticancer Therapeutic Inv Sa | Method of radiotherapy |
| US7794691B2 (en) * | 2004-06-25 | 2010-09-14 | The European Community, Represented By The European Commission | Radionuclides for medical use |
| CA2570191C (en) * | 2004-06-25 | 2015-04-28 | The European Community, Represented By The European Commission | Radionuclides for medical use |
| US8173800B2 (en) | 2006-08-15 | 2012-05-08 | The Regents Of The University Of California | Luminescent macrocyclic lanthanide complexes |
| US8158804B2 (en) | 2007-01-11 | 2012-04-17 | Ge Healthcare As | Chelating agents |
| CN104710504B (zh) * | 2009-07-22 | 2019-09-13 | 锕医药股份有限公司 | 用于制备放射性免疫缀合物的方法 |
| JP2013515744A (ja) * | 2009-12-24 | 2013-05-09 | ルミフォア，インコーポレイテッド | 放射性医薬品錯体 |
| ES2496991T3 (es) * | 2010-02-12 | 2014-09-22 | Evonik Degussa Gmbh | Composición cosmética que contiene éster parcial de poliglicerol |
| GB201002508D0 (en) | 2010-02-12 | 2010-03-31 | Algeta As | Product |
| GB201208309D0 (en) | 2012-05-11 | 2012-06-27 | Algeta As | Complexes |
-
2012
- 2012-05-11 GB GB201208309A patent/GB201208309D0/en not_active Ceased
-
2013
- 2013-05-13 CN CN201380036807.4A patent/CN104619355A/zh active Pending
- 2013-05-13 WO PCT/EP2013/059841 patent/WO2013167756A1/en not_active Ceased
- 2013-05-13 EP EP13721975.4A patent/EP2846843A1/en not_active Withdrawn
- 2013-05-13 CA CA2873142A patent/CA2873142A1/en not_active Abandoned
- 2013-05-13 EP EP13721784.0A patent/EP2846842A1/en not_active Withdrawn
- 2013-05-13 WO PCT/EP2013/059839 patent/WO2013167754A1/en not_active Ceased
- 2013-05-13 KR KR1020147034742A patent/KR20150092701A/ko not_active Withdrawn
- 2013-05-13 KR KR1020147034741A patent/KR20150092700A/ko not_active Withdrawn
- 2013-05-13 HK HK15107608.2A patent/HK1206981A1/xx unknown
- 2013-05-13 CA CA 2873143 patent/CA2873143A1/en not_active Abandoned
- 2013-05-13 JP JP2015510838A patent/JP6211066B2/ja not_active Expired - Fee Related
- 2013-05-13 US US14/400,031 patent/US20150147272A1/en not_active Abandoned
- 2013-05-13 CA CA2873144A patent/CA2873144C/en not_active Expired - Fee Related
- 2013-05-13 JP JP2015510839A patent/JP2015523326A/ja active Pending
- 2013-05-13 KR KR1020147034743A patent/KR20150092702A/ko not_active Withdrawn
- 2013-05-13 CN CN201380035189.1A patent/CN104602716A/zh active Pending
- 2013-05-13 CN CN201380036905.8A patent/CN104540530A/zh active Pending
- 2013-05-13 US US14/400,026 patent/US9827336B2/en not_active Expired - Fee Related
- 2013-05-13 WO PCT/EP2013/059840 patent/WO2013167755A1/en not_active Ceased
- 2013-05-13 HK HK15108017.5A patent/HK1207307A1/xx unknown
- 2013-05-13 HK HK15107609.1A patent/HK1206982A1/xx unknown
- 2013-05-13 EP EP13725586.5A patent/EP2846844B1/en active Active
- 2013-05-13 JP JP2015510840A patent/JP6219372B2/ja not_active Expired - Fee Related
- 2013-05-13 US US14/400,020 patent/US20150104385A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015517482A5 (https=) | ||
| JP2015523326A5 (https=) | ||
| SI2533817T1 (en) | Target complexes that emit alpha particles containing thorium radionuclide and a ligand containing hydroxypyridinone | |
| JP6211066B2 (ja) | 放射性医薬錯体 | |
| RU2503687C2 (ru) | Сшивающие реагенты и их применение | |
| CN110357967B (zh) | 新型成像组合物及其用途 | |
| PH12021552831A1 (en) | Mcl-1 inhibitor antibody-drug conjugates and methods of use | |
| JP2010535713A5 (https=) | ||
| TWI654179B (zh) | 放射性醫藥複合物 | |
| RU2016150377A (ru) | Сайт-специфичная конъюгация линкерных лекарственных препаратов с антителами и получаемые в результате adc | |
| SI2894162T1 (en) | Identification of tumor-associated antigens for diagnosis and therapy | |
| MX2024005950A (es) | Radioligandos escindibles para dirigirse a receptores de la superficie celular y sus usos. | |
| RU2019111303A (ru) | Антитела против edb и конъюгаты антитело-лекарственное средство | |
| RU2016116549A (ru) | Антитела против epcam и способы их применения | |
| JP2021503915A5 (https=) | ||
| MX2024014265A (es) | Complejos radiofarmaceuticos dirigidos al antigeno prostatico especifico de membrana y sus combinaciones | |
| JP2016540826A5 (https=) | ||
| ATE461713T1 (de) | Zusammensetzungen für die radioimmuntherapie von gehirn-tumoren | |
| Nie et al. | Small-Cell Lung Cancer Updates | |
| Lewis et al. | Models for B12-conjugated radiopharmaceuticals. Cobaloxime binding to new fac-[Re (CO) 3 (Me2bipyridine)(amidine)] BF4 complexes having an exposed pyridyl nitrogen | |
| NZ766904A (en) | Amanitin antibody conjugate | |
| NZ766904B2 (en) | Amanitin antibody conjugate | |
| AR070280A1 (es) | Anticuerpos monoclonales modificadores de enfermedades cancerosas (cdmab) | |
| TH1801005806A (th) | สารเชิงซ้อนทางเภสัชกรรมกัมมันตรังสี | |
| NZ777968B2 (en) | Multispecific antigen-binding molecules and uses thereof |